Depression is a consequence of drug abuse, says 'Queen' actor

Also In This Package
Top 7 reasons why ‘Yeh Jawaani Hai Deewani’ still works
How WHO has Deepika, Priyanka fight the coronavirus
Virat Kohli to Deepika: Meet India's Instagram stars
8 candid confessions by Bollywood star Deepika Padukone
Star investor Priyanka Chopra launches homeware line
COVID-19: Deepika, Alia turn chefs during lockdown
Kangana Ranaut has taken a sarcastic jibe at Deepika Padukone, saying depression is a consequence of drug abuse.
Ranaut took to her verified Twitter account to take a dig at Padukone using the latter's name in a hashtag, leaving no guesses as to who her comment was aimed at.
Also Read
Urmila Matondkar vs Kangana Ranaut: Bollywood reacts to actress' spatThe 'Queen' of controversy: Why Bollywood loves to hate Kangana RanautJaya Bachchan defends Bollywood in Parliament: Kangana Ranaut, Sonam Kapoor reactFrom Salman Khan to Kangana Ranaut, Bollywood celebrates PM Narendra Modi’s birthday"Repeat after me, depression is a consequence of drug abuse. So called high society rich star children who claim to be classy and have a good upbringing ask their manager," MAAL HAI KYA?" #boycottBollywoodDruggies #DeepikaPadukone," Ranaut tweeted.
Just a day after Sushant Singh Rajput's death, on June 15, Padukone had tweeted from her verified account: "Repeat after me: depression is an illness." In another tweet posted on June 16, the actress had shared: "Repeat after me: depression is a form of mental illness."
Ranaut in her tweets has now taken a sarcastic jibe at Padukone using the latter's catchwords in her anti-depression campaigns. Ranaut's jibe at Padukone comes after the news channel Times Now revealed a WhatsApp chat, which the channel claims allegedly took place between Padukone and her manager Karishma Prakash, who is reportedly an employee with Kwan Talent Management Agency.
Sign up for the Daily Briefing
Get the latest news and updates straight to your inbox
Network Links
GN StoreDownload our app
© Al Nisr Publishing LLC 2026. All rights reserved.